ISRG Stock Overview

Develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. More details

ISRG fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	3/6
Past Performance	5/6
Financial Health	6/6
Dividends	0/6

Rewards

Earnings are forecast to grow 11.48% per year

Earnings grew by 47.9% over the past year

Risk Analysis

No risks detected for ISRG from our risk checks.

Intuitive Surgical, Inc. Competitors

Stryker

NYSE:SYK

US$148.6b

Boston Scientific

NYSE:BSX

US$133.9b

Abbott Laboratories

NYSE:ABT

US$201.1b

Medtronic

NYSE:MDT

US$109.4b

Price History & Performance

Summary of all time highs, changes and price drops for Intuitive Surgical
Historical stock prices
Current Share Price	US$6,700.00
52 Week High	US$7,100.00
52 Week Low	US$6,390.00
Beta	1.39
11 Month Change	-1.47%
3 Month Change	n/a
1 Year Change	n/a
33 Year Change	n/a
5 Year Change	n/a
Change since IPO	-5.63%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	ISRG	AR Medical Equipment	AR Market
7D	0%	0%	0%
1Y	n/a	0%	0%

Return vs Industry: Insufficient data to determine how ISRG performed against the AR Medical Equipment industry.

Return vs Market: Insufficient data to determine how ISRG performed against the AR Market.

Price Volatility

Is ISRG's price volatile compared to industry and market?
ISRG volatility
ISRG Average Weekly Movement	3.9%
Medical Equipment Industry Average Movement	0%
Market Average Movement	0%
10% most volatile stocks in AR Market	0%
10% least volatile stocks in AR Market	0%

Stable Share Price: ISRG has not had significant price volatility in the past 3 months compared to the AR market.

Volatility Over Time: Insufficient data to determine ISRG's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1995	13,676	Gary Guthart	www.intuitive.com

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights.

Intuitive Surgical, Inc. Fundamentals Summary

How do Intuitive Surgical's earnings and revenue compare to its market cap?
ISRG fundamental statistics
Market cap	AR$198.47t
Earnings (TTM)	AR$2.27t
Revenue (TTM)	AR$7.97t

87.3x

P/E Ratio

24.9x

P/S Ratio

Is ISRG overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ISRG income statement (TTM)
Revenue	US$7.87b
Cost of Revenue	US$2.60b
Gross Profit	US$5.27b
Other Expenses	US$3.03b
Earnings	US$2.24b

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	6.30
Gross Margin	66.98%
Net Profit Margin	28.51%
Debt/Equity Ratio	0%

How did ISRG perform over the long term?

See historical performance and comparison